315 related articles for article (PubMed ID: 28351336)
1. B-cell lymphoma 2 inhibitor ABT-737 induces Beclin1- and reactive oxygen species-dependent autophagy in Adriamycin-resistant human hepatocellular carcinoma cells.
Yao X; Li X; Zhang D; Xie Y; Sun B; Li H; Sun L; Zhang X
Tumour Biol; 2017 Mar; 39(3):1010428317695965. PubMed ID: 28351336
[TBL] [Abstract][Full Text] [Related]
2. HCC cells with high levels of Bcl-2 are resistant to ABT-737 via activation of the ROS-JNK-autophagy pathway.
Ni Z; Wang B; Dai X; Ding W; Yang T; Li X; Lewin S; Xu L; Lian J; He F
Free Radic Biol Med; 2014 May; 70():194-203. PubMed ID: 24576507
[TBL] [Abstract][Full Text] [Related]
3. Curcumin enhances the antitumor effect of ABT-737 via activation of the ROS-ASK1-JNK pathway in hepatocellular carcinoma cells.
Zheng R; You Z; Jia J; Lin S; Han S; Liu A; Long H; Wang S
Mol Med Rep; 2016 Feb; 13(2):1570-6. PubMed ID: 26707143
[TBL] [Abstract][Full Text] [Related]
4. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC
Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting ROS-STAT3-dependent autophagy enhanced capsaicin-induced apoptosis in human hepatocellular carcinoma cells.
Chen X; Tan M; Xie Z; Feng B; Zhao Z; Yang K; Hu C; Liao N; Wang T; Chen D; Xie F; Tang C
Free Radic Res; 2016 Jul; 50(7):744-55. PubMed ID: 27043357
[TBL] [Abstract][Full Text] [Related]
6. The Bcl-xL inhibitor, ABT-737, efficiently induces apoptosis and suppresses growth of hepatoma cells in combination with sorafenib.
Hikita H; Takehara T; Shimizu S; Kodama T; Shigekawa M; Iwase K; Hosui A; Miyagi T; Tatsumi T; Ishida H; Li W; Kanto T; Hiramatsu N; Hayashi N
Hepatology; 2010 Oct; 52(4):1310-21. PubMed ID: 20799354
[TBL] [Abstract][Full Text] [Related]
7. Role and mechanisms of microRNA‑503 in drug resistance reversal in HepG2/ADM human hepatocellular carcinoma cells.
Wang D; Zhang N; Ye Y; Qian J; Zhu Y; Wang C
Mol Med Rep; 2014 Dec; 10(6):3268-74. PubMed ID: 25269574
[TBL] [Abstract][Full Text] [Related]
8. Norcantharidin combined with ABT-737 for hepatocellular carcinoma: Therapeutic effects and molecular mechanisms.
Ren J; Li G; Zhao W; Lin L; Ye T
World J Gastroenterol; 2016 Apr; 22(15):3962-8. PubMed ID: 27099439
[TBL] [Abstract][Full Text] [Related]
9. The Bcl-2 homology domain 3 mimetic ABT-737 targets the apoptotic machinery in acute lymphoblastic leukemia resulting in synergistic in vitro and in vivo interactions with established drugs.
High LM; Szymanska B; Wilczynska-Kalak U; Barber N; O'Brien R; Khaw SL; Vikstrom IB; Roberts AW; Lock RB
Mol Pharmacol; 2010 Mar; 77(3):483-94. PubMed ID: 20038611
[TBL] [Abstract][Full Text] [Related]
10. The Sineoculis Homeobox Homolog 1 (SIX1) Gene Regulates Paclitaxel Resistance by Affecting Reactive Oxygen Species and Autophagy in Human Hepatocellular Carcinoma Cell Line HepG2.
Li B; Zhao S; Geng R; Huo Z; Zhang H
Med Sci Monit; 2018 Apr; 24():2271-2279. PubMed ID: 29656300
[TBL] [Abstract][Full Text] [Related]
11. [Establishment of human hepatocellular carcinoma multidrug-resistance cell line (HepG2/Adm) and study apoptosis induced by low-frequency pulse ultrasound exposure].
Zhai BJ; Wu F; Shao ZY; Hu K; Zhao CL; Wang ZB
Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):95-8. PubMed ID: 14980111
[TBL] [Abstract][Full Text] [Related]
12. Bcl2L12 with a BH3-like domain in regulating apoptosis and TMZ-induced autophagy: a prospective combination of ABT-737 and TMZ for treating glioma.
Yang MC; Loh JK; Li YY; Huang WS; Chou CH; Cheng JT; Wang YT; Lieu AS; Howng SL; Hong YR; Chou AK
Int J Oncol; 2015 Mar; 46(3):1304-16. PubMed ID: 25586056
[TBL] [Abstract][Full Text] [Related]
13. Bauerenol, a triterpenoid from Indian Suregada angustifolia: Induces reactive oxygen species-mediated P38MAPK activation and apoptosis in human hepatocellular carcinoma (HepG2) cells.
Sathish Kumar P; Viswanathan MBG; Venkatesan M; Balakrishna K
Tumour Biol; 2017 Apr; 39(4):1010428317698387. PubMed ID: 28443465
[TBL] [Abstract][Full Text] [Related]
14. Norcantharidin enhances ABT-737-induced apoptosis in hepatocellular carcinoma cells by transcriptional repression of Mcl-1.
Zhang S; Li G; Ma X; Wang Y; Liu G; Feng L; Zhao Y; Zhang G; Wu Y; Ye X; Qin B; Lu J
Cell Signal; 2012 Sep; 24(9):1803-9. PubMed ID: 22609455
[TBL] [Abstract][Full Text] [Related]
15. [Effect of inhibiting survivin expression with antisense oligodeoxynucleotides on sensitivity of hepatocellular carcinoma cell lines HepG2 and HepG2/ADM to adriamycin].
Dai DJ; Lu CD; Guo JM; Zhang J
Ai Zheng; 2005 Aug; 24(8):951-7. PubMed ID: 16086872
[TBL] [Abstract][Full Text] [Related]
16. Extracellular Ca(2+) Selectively Enhances Adriamycin-induced Cell Death in Human Hepatoma Cells.
Huang X; Xu Y; Liu Y; Xie H; Wang J; Wu Z
Curr Cancer Drug Targets; 2015; 15(6):481-92. PubMed ID: 26282547
[TBL] [Abstract][Full Text] [Related]
17. Rosmarinic Acid Combined with Adriamycin Induces Apoptosis by Triggering Mitochondria-Mediated Signaling Pathway in HepG2 and Bel-7402 Cells.
Huang Y; Cai Y; Huang R; Zheng X
Med Sci Monit; 2018 Nov; 24():7898-7908. PubMed ID: 30391993
[TBL] [Abstract][Full Text] [Related]
18. [Bcl-2 inhibitor ABT-737 enhances the cisplatin-induced apoptosis in breast cancer T47D cells].
Chen ZJ; Zhang B; Pan SH; Zhao HM; Zhang Y; Feng WH; Li YY; Cao XC
Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):891-5. PubMed ID: 22340096
[TBL] [Abstract][Full Text] [Related]
19. Effect of dual inhibition of apoptosis and autophagy in prostate cancer.
Saleem A; Dvorzhinski D; Santanam U; Mathew R; Bray K; Stein M; White E; DiPaola RS
Prostate; 2012 Sep; 72(12):1374-81. PubMed ID: 22241682
[TBL] [Abstract][Full Text] [Related]
20. Combined Bcl-2/mammalian target of rapamycin inhibition leads to enhanced radiosensitization via induction of apoptosis and autophagy in non-small cell lung tumor xenograft model.
Kim KW; Moretti L; Mitchell LR; Jung DK; Lu B
Clin Cancer Res; 2009 Oct; 15(19):6096-105. PubMed ID: 19773376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
